Radioactive drug targets tough lung cancers in early trial
NCT ID NCT06736418
First seen Feb 26, 2026 · Last updated Jun 18, 2026 · Updated 16 times
Summary
This early-phase study tests a new radioactive drug, 225Ac-ABD147, in people with small cell lung cancer or large cell neuroendocrine lung cancer that has spread and was previously treated with platinum chemotherapy. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. About 17 participants will receive the drug, and some will also get an imaging agent to see where the drug goes in the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER (SCLC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Florida Cancer Specialists - Sarasota
Sarasota, Florida, 34232, United States
-
Hoag Memorial Hospital Presbyterian
Newport Beach, California, 92663, United States
-
Huntsman Cancer Institute
Salt Lake City, Utah, 84112, United States
-
MD Anderson
Houston, Texas, 77030, United States
-
Mayo Clinic - Jacksonville
Jacksonville, Florida, 32224, United States
-
Mayo Clinic - Rochester
Rochester, Minnesota, 55905, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Sylvester Comprehensive Cancer Center, Univ of Miami
Miami, Florida, 33136, United States
-
United Theranostics
Glen Burnie, Maryland, 21061, United States
-
University of California, Los Angeles
Santa Monica, California, 90404, United States
-
University of California, San Francisco
San Francisco, California, 94143, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.